BIOGENEA

Biogenea pharmaceuticals is specialized and active in the wider field of pharmaceutical biotechnology, throughout Greece, emphasizing on the fields of stem cells, regenerative medicine and the field of genomics in the context of applicating the rules of precision medicine in clinical practice... Biogenea Pharmaceuticals Ltd established worldwide the normal range for the hematological parameters of umbilical cord blood, published in the prestigious international scientific journal LabMedicine, which was republished by one of America's largest medical journals, Stem Cell Week, belonging to one of America's largest publishers, NewsRxTM. Biogenea Pharmaceuticals Ltd's scientific staff published the protocol of isolation, processing and cryopreservation of Wharton's jelly mesenchymal cells of the umbilical cord tissue in the prestigious international scientific journal, In vitro cellular animal and developmental. At the same time, results of the basic research on the differentiation of..

Also known as: Biogenea Pharmaceuticals, Biogenea Pharmaceuticals Ltd